FDA NDC Directory · JSON-LD · Markdown

CINQAIR

NDC 59310-610 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameReslizumab
Labeler / ManufacturerTeva Respiratory, LLC
Marketing categoryBiologic License Application · App BLA761033
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsRESLIZUMAB (10 mg/mL)
Marketing started20160418
Package count1

External sources

Source: openFDA. Public-domain (CC0).